Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 121 entries
Sorted by: Best Match Show Resources per page
Response.

Radiology

Radbruch A, Weberling LD, Kieslich PJ, Eidel O, Burth S, Kickingereder P, Wick W, Schlemmer HP, Bendszus M.
PMID: 27437553
Radiology. 2016 Apr;279(1):324-5.

No abstract available.

Cite
Radbruch A, Weberling LD, Kieslich PJ, et al. Response. Radiology. 2016;279(1):324-5
Radbruch, A., Weberling, L. D., Kieslich, P. J., Eidel, O., Burth, S., Kickingereder, P., Wick, W., Schlemmer, H. P., & Bendszus, M. (2016). Response. Radiology, 279(1), 324-5.
Radbruch, Alexander, et al. "Response." Radiology vol. 279,1 (2016): 324-5.
Radbruch A, Weberling LD, Kieslich PJ, Eidel O, Burth S, Kickingereder P, Wick W, Schlemmer HP, Bendszus M. Response. Radiology. 2016 Apr;279(1):324-5. PMID: 27437553.
Copy Download .nbib Format: NLM
[Reviews].

NTM

Radbruch K, Tobies R, Handel K, Marz I.
PMID: 27518339
NTM. 1998 Dec;6(1):125-8. doi: 10.1007/BF02914214.

No abstract available.

Cite
Radbruch K, Tobies R, Handel K, et al. Rezensionen. [Reviews]. NTM. 1998;6(1):125-8doi: 10.1007/BF02914214.
Radbruch, K., Tobies, R., Handel, K., & Marz, I. (1998). Rezensionen. [Reviews]. NTM, 6(1), 125-8. https://doi.org/10.1007/BF02914214
Radbruch, K, et al. "Rezensionen." [Reviews]. NTM vol. 6,1 (1998): 125-8. doi: https://doi.org/10.1007/BF02914214
Radbruch K, Tobies R, Handel K, Marz I. Rezensionen. [Reviews]. NTM. 1998 Dec;6(1):125-8. doi: 10.1007/BF02914214. German. PMID: 27518339.
Copy Download .nbib Format: NLM
Building a taxonomy of integrated palliative care initiatives: results from a focus group.

BMJ supportive & palliative care

Ewert B, Hodiamont F, van Wijngaarden J, Payne S, Groot M, Hasselaar J, Menten J, Radbruch L.
PMID: 26647043
BMJ Support Palliat Care. 2016 Mar;6(1):14-20. doi: 10.1136/bmjspcare-2014-000841. Epub 2015 Dec 08.

BACKGROUND: Empirical evidence suggests that integrated palliative care (IPC) increases the quality of care for palliative patients and supports professional caregivers. Existing IPC initiatives in Europe vary in their design and are hardly comparable. InSuP-C, a European Union research...

Cite
Ewert B, Hodiamont F, van Wijngaarden J, et al. Building a taxonomy of integrated palliative care initiatives: results from a focus group. BMJ Support Palliat Care. 2015;6(1):14-20doi: 10.1136/bmjspcare-2014-000841.
Ewert, B., Hodiamont, F., van Wijngaarden, J., Payne, S., Groot, M., Hasselaar, J., Menten, J., & Radbruch, L. (2016). Building a taxonomy of integrated palliative care initiatives: results from a focus group. BMJ supportive & palliative care, 6(1), 14-20. https://doi.org/10.1136/bmjspcare-2014-000841
Ewert, Benjamin, et al. "Building a taxonomy of integrated palliative care initiatives: results from a focus group." BMJ supportive & palliative care vol. 6,1 (2016): 14-20. doi: https://doi.org/10.1136/bmjspcare-2014-000841
Ewert B, Hodiamont F, van Wijngaarden J, Payne S, Groot M, Hasselaar J, Menten J, Radbruch L. Building a taxonomy of integrated palliative care initiatives: results from a focus group. BMJ Support Palliat Care. 2016 Mar;6(1):14-20. doi: 10.1136/bmjspcare-2014-000841. Epub 2015 Dec 08. PMID: 26647043; PMCID: PMC4789694.
Copy Download .nbib Format: NLM
Ongoing Oxidative Stress Causes Subclinical Neuronal Dysfunction in the Recovery Phase of EAE.

Frontiers in immunology

Radbruch H, Bremer D, Guenther R, Cseresnyes Z, Lindquist R, Hauser AE, Niesner R.
PMID: 27014271
Front Immunol. 2016 Mar 14;7:92. doi: 10.3389/fimmu.2016.00092. eCollection 2016.

Most multiple sclerosis (MS) patients develop over time a secondary progressive disease course, characterized histologically by axonal loss and atrophy. In early phases of the disease, focal inflammatory demyelination leads to functional impairment, but the mechanism of chronic progression...

Cite
Radbruch H, Bremer D, Guenther R, et al. Ongoing Oxidative Stress Causes Subclinical Neuronal Dysfunction in the Recovery Phase of EAE. Front Immunol. 2016;7:92doi: 10.3389/fimmu.2016.00092.
Radbruch, H., Bremer, D., Guenther, R., Cseresnyes, Z., Lindquist, R., Hauser, A. E., & Niesner, R. (2016). Ongoing Oxidative Stress Causes Subclinical Neuronal Dysfunction in the Recovery Phase of EAE. Frontiers in immunology, 792. https://doi.org/10.3389/fimmu.2016.00092
Radbruch, Helena, et al. "Ongoing Oxidative Stress Causes Subclinical Neuronal Dysfunction in the Recovery Phase of EAE." Frontiers in immunology vol. 7 (2016): 92. doi: https://doi.org/10.3389/fimmu.2016.00092
Radbruch H, Bremer D, Guenther R, Cseresnyes Z, Lindquist R, Hauser AE, Niesner R. Ongoing Oxidative Stress Causes Subclinical Neuronal Dysfunction in the Recovery Phase of EAE. Front Immunol. 2016 Mar 14;7:92. doi: 10.3389/fimmu.2016.00092. eCollection 2016. PMID: 27014271; PMCID: PMC4789534.
Copy Download .nbib Format: NLM
Pharmacological treatments for fatigue associated with palliative care: executive summary of a Cochrane Collaboration systematic review.

Journal of cachexia, sarcopenia and muscle

Mücke M, Mochamat, Cuhls H, Peuckmann-Post V, Minton O, Stone P, Radbruch L.
PMID: 27066315
J Cachexia Sarcopenia Muscle. 2016 Mar;7(1):23-7. doi: 10.1002/jcsm.12101. Epub 2016 Feb 10.

BACKGROUND: In palliative care patients, fatigue can be severely debilitating and is often not counteracted with rest, thereby impacting daily activity and quality of life. Further complicating issues are the multidimensionality, subjective nature and lack of a consensus definition...

Cite
Mücke M, Mochamat, Cuhls H, et al. Pharmacological treatments for fatigue associated with palliative care: executive summary of a Cochrane Collaboration systematic review. J Cachexia Sarcopenia Muscle. 2016;7(1):23-7doi: 10.1002/jcsm.12101.
Mücke, M., Mochamat, Cuhls, H., Peuckmann-Post, V., Minton, O., Stone, P., & Radbruch, L. (2016). Pharmacological treatments for fatigue associated with palliative care: executive summary of a Cochrane Collaboration systematic review. Journal of cachexia, sarcopenia and muscle, 7(1), 23-7. https://doi.org/10.1002/jcsm.12101
Mücke, Martin, et al. "Pharmacological treatments for fatigue associated with palliative care: executive summary of a Cochrane Collaboration systematic review." Journal of cachexia, sarcopenia and muscle vol. 7,1 (2016): 23-7. doi: https://doi.org/10.1002/jcsm.12101
Mücke M, Mochamat, Cuhls H, Peuckmann-Post V, Minton O, Stone P, Radbruch L. Pharmacological treatments for fatigue associated with palliative care: executive summary of a Cochrane Collaboration systematic review. J Cachexia Sarcopenia Muscle. 2016 Mar;7(1):23-7. doi: 10.1002/jcsm.12101. Epub 2016 Feb 10. PMID: 27066315; PMCID: PMC4799864.
Copy Download .nbib Format: NLM
[Weak opioids. Meta-analysis for the therapy of chronic pain].

Schmerz (Berlin, Germany)

Grond S, Radbruch L.
PMID: 12799983
Schmerz. 1998 Apr 20;12(2):142-55. doi: 10.1007/s004829800055.

Weak opioids have a maximal dose (ceiling effect), and their distribution and prescription is not controlled by German narcotic laws. In a literature search (Medline 1963-1995) and our own literature database on pain treatment, 58 publications were identified. These...

Cite
Grond S, Radbruch L. Schwach wirksame Opioide. Metaanalyse zur Therapie chronischer Schmerzen. [Weak opioids. Meta-analysis for the therapy of chronic pain]. Schmerz. 1998;12(2):142-55doi: 10.1007/s004829800055.
Grond, S., & Radbruch, L. (1998). Schwach wirksame Opioide. Metaanalyse zur Therapie chronischer Schmerzen. [Weak opioids. Meta-analysis for the therapy of chronic pain]. Schmerz (Berlin, Germany), 12(2), 142-55. https://doi.org/10.1007/s004829800055
Grond, S, and Radbruch, L. "Schwach wirksame Opioide. Metaanalyse zur Therapie chronischer Schmerzen." [Weak opioids. Meta-analysis for the therapy of chronic pain]. Schmerz (Berlin, Germany) vol. 12,2 (1998): 142-55. doi: https://doi.org/10.1007/s004829800055
Grond S, Radbruch L. Schwach wirksame Opioide. Metaanalyse zur Therapie chronischer Schmerzen. [Weak opioids. Meta-analysis for the therapy of chronic pain]. Schmerz. 1998 Apr 20;12(2):142-55. doi: 10.1007/s004829800055. German. PMID: 12799983.
Copy Download .nbib Format: NLM
[MIDOS--validation of a minimal documentation system for palliative medicine].

Schmerz (Berlin, Germany)

Radbruch L, Sabatowski R, Loick G, Jonen-Thielemann I, Elsner F, Hörmann E.
PMID: 12800029
Schmerz. 2000 Aug;14(4):231-9. doi: 10.1007/s004820000034.

INTRODUCTION: Repeated assessment of pain and other symptoms is required for quality assurance in palliative care. However, physical and cognitive impairment of the patients may impede the use of standardized questionnaires and documentation systems in palliative care setting. We...

Cite
Radbruch L, Sabatowski R, Loick G, et al. MIDOS Validierung eines minimalen Dokumentationssystems für die Palliativmedizin. [MIDOS--validation of a minimal documentation system for palliative medicine]. Schmerz. 2000;14(4):231-9doi: 10.1007/s004820000034.
Radbruch, L., Sabatowski, R., Loick, G., Jonen-Thielemann, I., Elsner, F., & Hörmann, E. (2000). MIDOS Validierung eines minimalen Dokumentationssystems für die Palliativmedizin. [MIDOS--validation of a minimal documentation system for palliative medicine]. Schmerz (Berlin, Germany), 14(4), 231-9. https://doi.org/10.1007/s004820000034
Radbruch, L, et al. "MIDOS Validierung eines minimalen Dokumentationssystems für die Palliativmedizin." [MIDOS--validation of a minimal documentation system for palliative medicine]. Schmerz (Berlin, Germany) vol. 14,4 (2000): 231-9. doi: https://doi.org/10.1007/s004820000034
Radbruch L, Sabatowski R, Loick G, Jonen-Thielemann I, Elsner F, Hörmann E. MIDOS Validierung eines minimalen Dokumentationssystems für die Palliativmedizin. [MIDOS--validation of a minimal documentation system for palliative medicine]. Schmerz. 2000 Aug;14(4):231-9. doi: 10.1007/s004820000034. German. PMID: 12800029.
Copy Download .nbib Format: NLM
[Switching opioids to transdermal fentanyl in a clinical setting].

Schmerz (Berlin, Germany)

Elsner F, Radbruch L, Sabatowski R, Brunsch-Radbruch A, Loick G, Grond S.
PMID: 12799928
Schmerz. 1999 Aug 19;13(4):273-8. doi: 10.1007/s004829900005.

INTRODUCTION: The use of transdermal fentanyl is gaining in importance in the management of cancer pain. We describe the reasons for switching opioid medication to transdermal fentanyl in a pain management unit.METHODS: Case records of patients treated with transdermal...

Cite
Elsner F, Radbruch L, Sabatowski R, et al. Opioidwechsel auf transdermales Fentanyl im klinischen Alltag. [Switching opioids to transdermal fentanyl in a clinical setting]. Schmerz. 1999;13(4):273-8doi: 10.1007/s004829900005.
Elsner, F., Radbruch, L., Sabatowski, R., Brunsch-Radbruch, A., Loick, G., & Grond, S. (1999). Opioidwechsel auf transdermales Fentanyl im klinischen Alltag. [Switching opioids to transdermal fentanyl in a clinical setting]. Schmerz (Berlin, Germany), 13(4), 273-8. https://doi.org/10.1007/s004829900005
Elsner, F, et al. "Opioidwechsel auf transdermales Fentanyl im klinischen Alltag." [Switching opioids to transdermal fentanyl in a clinical setting]. Schmerz (Berlin, Germany) vol. 13,4 (1999): 273-8. doi: https://doi.org/10.1007/s004829900005
Elsner F, Radbruch L, Sabatowski R, Brunsch-Radbruch A, Loick G, Grond S. Opioidwechsel auf transdermales Fentanyl im klinischen Alltag. [Switching opioids to transdermal fentanyl in a clinical setting]. Schmerz. 1999 Aug 19;13(4):273-8. doi: 10.1007/s004829900005. German. PMID: 12799928.
Copy Download .nbib Format: NLM
Palliative care research--priorities and the way forward.

European journal of cancer (Oxford, England : 1990)

Kaasa S, Radbruch L.
PMID: 18374560
Eur J Cancer. 2008 May;44(8):1175-9. doi: 10.1016/j.ejca.2008.02.036. Epub 2008 Apr 18.

Palliative care is developed primarily outside academic institutions and with a primary focus upon service development. Initiatives to formalise the research structure were taken in Europe in 1996 by the European Association for Palliative Care (EAPC) through the establishment...

Cite
Kaasa S, Radbruch L. Palliative care research--priorities and the way forward. Eur J Cancer. 2008;44(8):1175-9doi: 10.1016/j.ejca.2008.02.036.
Kaasa, S., & Radbruch, L. (2008). Palliative care research--priorities and the way forward. European journal of cancer (Oxford, England : 1990), 44(8), 1175-9. https://doi.org/10.1016/j.ejca.2008.02.036
Kaasa, Stein, and Radbruch, Lukas. "Palliative care research--priorities and the way forward." European journal of cancer (Oxford, England : 1990) vol. 44,8 (2008): 1175-9. doi: https://doi.org/10.1016/j.ejca.2008.02.036
Kaasa S, Radbruch L. Palliative care research--priorities and the way forward. Eur J Cancer. 2008 May;44(8):1175-9. doi: 10.1016/j.ejca.2008.02.036. Epub 2008 Apr 18. PMID: 18374560.
Copy Download .nbib Format: NLM
[Prevalence and characteristics of neuropathic pain in malignant disease.].

Schmerz (Berlin, Germany)

Grond S, Zech D, Meuser T, Radbruch L, Kasper M, Lehmann KA.
PMID: 18415614
Schmerz. 1992 Jun;6(2):99-104. doi: 10.1007/BF02528125.

Neuropathic pain is one of the problem areas in the management of cancer pain. In a retrospective study, prevalence and characteristics of neuropathic pain in 1318 cancer patients attending a pain clinic were examined. Of the patients, 135 suffered...

Cite
Grond S, Zech D, Meuser T, et al. Prävalenz und Charakteristik neuropathischer Schmerzen bei malignen Erkrankungen. [Prevalence and characteristics of neuropathic pain in malignant disease.]. Schmerz. 1992;6(2):99-104doi: 10.1007/BF02528125.
Grond, S., Zech, D., Meuser, T., Radbruch, L., Kasper, M., & Lehmann, K. A. (1992). Prävalenz und Charakteristik neuropathischer Schmerzen bei malignen Erkrankungen. [Prevalence and characteristics of neuropathic pain in malignant disease.]. Schmerz (Berlin, Germany), 6(2), 99-104. https://doi.org/10.1007/BF02528125
Grond, S, et al. "Prävalenz und Charakteristik neuropathischer Schmerzen bei malignen Erkrankungen." [Prevalence and characteristics of neuropathic pain in malignant disease.]. Schmerz (Berlin, Germany) vol. 6,2 (1992): 99-104. doi: https://doi.org/10.1007/BF02528125
Grond S, Zech D, Meuser T, Radbruch L, Kasper M, Lehmann KA. Prävalenz und Charakteristik neuropathischer Schmerzen bei malignen Erkrankungen. [Prevalence and characteristics of neuropathic pain in malignant disease.]. Schmerz. 1992 Jun;6(2):99-104. doi: 10.1007/BF02528125. German. PMID: 18415614.
Copy Download .nbib Format: NLM
[Der Schmerz - the leading German-language pain journal].

Schmerz (Berlin, Germany)

Radbruch L, Schaible HG.
PMID: 25465245
Schmerz. 2014 Dec;28(6):569-70. doi: 10.1007/s00482-014-1498-z.

No abstract available.

Cite
Radbruch L, Schaible HG. Der Schmerz - die führende deutschsprachige Schmerzzeitschrift. [Der Schmerz - the leading German-language pain journal]. Schmerz. 2014;28(6):569-70doi: 10.1007/s00482-014-1498-z.
Radbruch, L., & Schaible, H. G. (2014). Der Schmerz - die führende deutschsprachige Schmerzzeitschrift. [Der Schmerz - the leading German-language pain journal]. Schmerz (Berlin, Germany), 28(6), 569-70. https://doi.org/10.1007/s00482-014-1498-z
Radbruch, L, and Schaible, H-G. "Der Schmerz - die führende deutschsprachige Schmerzzeitschrift." [Der Schmerz - the leading German-language pain journal]. Schmerz (Berlin, Germany) vol. 28,6 (2014): 569-70. doi: https://doi.org/10.1007/s00482-014-1498-z
Radbruch L, Schaible HG. Der Schmerz - die führende deutschsprachige Schmerzzeitschrift. [Der Schmerz - the leading German-language pain journal]. Schmerz. 2014 Dec;28(6):569-70. doi: 10.1007/s00482-014-1498-z. German. PMID: 25465245.
Copy Download .nbib Format: NLM
The European Association for Palliative Care basic dataset to describe a palliative care cancer population: Results from an international Delphi process.

Palliative medicine

Sigurdardottir KR, Kaasa S, Rosland JH, Bausewein C, Radbruch L, Haugen DF.
PMID: 24503559
Palliat Med. 2014 Jun;28(6):463-473. doi: 10.1177/0269216314521264.

BACKGROUND: One of the barriers identified in palliative care research is the lack of common criteria to describe the population.AIM: The aim of this Delphi process was to obtain consensus on a basic set of core variables to describe...

Cite
Sigurdardottir KR, Kaasa S, Rosland JH, et al. The European Association for Palliative Care basic dataset to describe a palliative care cancer population: Results from an international Delphi process. Palliat Med. 2014;28(6):463-473doi: 10.1177/0269216314521264.
Sigurdardottir, K. R., Kaasa, S., Rosland, J. H., Bausewein, C., Radbruch, L., Haugen, D. F. (2014). The European Association for Palliative Care basic dataset to describe a palliative care cancer population: Results from an international Delphi process. Palliative medicine, 28(6), 463-473. https://doi.org/10.1177/0269216314521264
Sigurdardottir, Katrin R, et al. "The European Association for Palliative Care basic dataset to describe a palliative care cancer population: Results from an international Delphi process." Palliative medicine vol. 28,6 (2014): 463-473. doi: https://doi.org/10.1177/0269216314521264
Sigurdardottir KR, Kaasa S, Rosland JH, Bausewein C, Radbruch L, Haugen DF. The European Association for Palliative Care basic dataset to describe a palliative care cancer population: Results from an international Delphi process. Palliat Med. 2014 Jun;28(6):463-473. doi: 10.1177/0269216314521264. PMID: 24503559.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 121 entries